Biologic tumor necrosis factor inhibitors in pre-filled syringe or autoinjector formats, manufactured by pharmaceutical companies and distributed to hospitals, rheumatology clinics, and specialty pharmacies for procurement by healthcare providers managing rheumatoid and psoriatic arthritis in outpatient settings.